Molecule Ecosystem, February 2024
VitaDAO Commits $2.5M to IPTs, EthDenver, & CerebrumDAO’s Call for Projects
VitaDAO commits to minting 10 IPTs by 2025
In a recent Snapshot vote, VitaDAO committed to channeling $2.5 million into 10 IPTs by 2025. VitaDAO was the first DAO to use Molecule’s IPT model when they created VITA-FAST - the sale of which went on to be a whopping 1700% oversubscribed. We’re happy to see this vote of confidence in our protocol and are looking forward to strides being made in the longevity field.
Remind me - what are IPTs?
Intellectual Property Tokens (IPTs) are the natural next step in decentralizing drug development, allowing individuals to directly interact with, and govern the IP produced by world-class scientists. Created from a parent IP-NFT, they are tradeable tokens that enable decentralized governance - essential in achieving truly democratic, community-led scientific progress.
ValleyDAO launches the Carbon Arc initiative
By Mark Lord, ValleyDAO Community Lead
The ValleyDAO community is proud to introduce the Carbon Arc; an initiative aimed at combating environmental challenges and supporting planetary health by addressing the translational gap in climate research, specifically in the field of synthetic biology. Focused on Carbon Capture and Utilization, the Carbon Arc campaign seeks to reframe carbon as a valuable resource and empower contributors of all backgrounds to help provide translational support in this area.
This campaign is a continuation of the impactful year the ValleyDAO community had in 2023, which was marked by community growth, funding achievements, and collaborative projects such as providing translational support to BioHalo.
By deploying a community of 1,500+ researchers, entrepreneurs, students and other experts into a single concentrated space, they aim to empower individuals to learn, contribute, and make a real impact on our climate.
Cerebrum DAO: Call for Projects
Cerebrum DAO & bio.xyz have been working behind the scenes, setting up for what is sure to be a cracking first year for the neurodegeneration DAO. Expect to see a lot more of them over the coming months. For now, there are a couple of ways to stay updated; you can check out their new website, join their Discord & join their token waitlist.
They’ve also made an official call for project submissions, focusing on the interplay between neuroinflammation and blood-brain barrier disruption in dementia. If you know anyone whose work fits this brief, please send them this link.
EthDenver & Desci Denver
Our Senior Developer Stefan Adolf gave us a little update on his time in Denver.
It was particularly exciting to see how various aspects of the DeSci ecosystem have started to converge. While Molecule approaches DeSci with our strong competence in fundraising, DAO operations and tokenomics, many projects are focussing on building infrastructure for decentralized publishing, knowledge sharing, peer reviews and decentralized journals, and of course Artificial Intelligence based tools that e.g. help solve "who said it first" use cases like Desci.World's Proof of Knowledge protocol.
I had highly fruitful meetings with uprising technology stars that might turn out highly impactful for the Molecule Catalyst and IP-NFT stacks like the schematized project description and data collection tool FirstApproval or the highly disruptive publishing and data collaboration solutions of Desci.Labs. Lastly, EthDenver of course held the main promise of an international conference that allowed me to have highly productive and very happy meets and greets with and put some faces to the Telegram handles of our valued infrastructure partners of Lit Protocol, Ceramic Network and OrbisD.
DeSci London
We’re going to be back at DeSci London this year, and we hope to see you there! The conference takes place over the 23rd & 24th of March at Imperial College London and has a strong focus on onboarding researchers into the DeSci community. You can buy tickets here - if you can’t make it there will also be a free online stream. Molecule’s Biotech Operations Manager, Logan Bishop-Currey and bio.xyz’s Project Manager, Leo Boltz, will be giving talks. Say hello if you see them!
If you’d like to hear more about the event you can listen to the DeSci Podcast’s latest episode with DeSci London co-founder Alfred Brown.
We’ve been listening to…
Our ever-active Product Director Benji Leibowitz sat down with BionicDAO to chat about Decentralized Science. Despite spending most of his time deep in the weeds of product, Benji is great at distilling the most high-level points; we’d suggest sending it to a new DeSci recruit! Listen to the full podcast here.
“Decentralization for us is a competitive advantage. Each of these DAOs has thousands to tens of thousands of members. Each one of them knows, probably, a thousand people. And so, your coverage over an idea space is super large.”
Do you know a killer Web3 growth lead?
We are looking for a Growth Lead to drive our efforts on our demand side. At its core, this role centers around scaling native web3 demand in our product pipeline (IP-NFTs, IPTs, etc.) and it demands a unique blend of strategic, product, and marketing insights and tactical execution with a strong focus on the crypto/Web3 community in the DeSci (Decentralized Science) space.
Interested candidates can email ezanne@molecule.to or view the job description at this link.
Thanks for Reading!
If you enjoyed this post, subscribe to our newsletter and stay updated as the ecosystem grows. Please reach out to us with any questions or ideas, visit our website, or join our Discord to interact directly with our team. We’re really looking forward to joining forces with our community to create a world where patients directly fund researchers developing the next therapeutic breakthrough they need and building an open, inclusive, and collaborative ecosystem.
Disclaimer: The views and opinions expressed in this newsletter are solely those of the individual authors and contributors. This content is provided for informational purposes only and should not be interpreted as investment advice, endorsement, or recommendation. Readers are advised to conduct their own research and consult with a professional advisor before making any investment decisions.